CFGS
RDHL

Concourse Financial Group Securities’s Redhill Biopharma RDHL Stock Holding History

Concourse Financial Group Securities’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Hold
0
– – – 2395
2021
Q4 		– Sell
-4
Closed -$16K – 2461
2021
Q3 		$17K Buy
+4
New +$27.1K ﹤0.01% 1715

Other funds holding RDHL

DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Concourse Financial Group Securities's RDHL Position: Q1 2022 in Review

Concourse Financial Group Securities held its Redhill Biopharma (RDHL) position steady in Q1 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Concourse Financial Group Securities first reported a position in RDHL in Q3 2021 and has held it in 1 quarter since. The position peaked at $17K in Q3 2021. 43 funds tracked by Wall St. Rank hold RDHL as of Q1 2022.

  • Concourse Financial Group Securities held 0 shares of Redhill Biopharma worth $0 as of Q1 2022.
  • Concourse Financial Group Securities left its Redhill Biopharma share count unchanged in Q1 2022.
  • Redhill Biopharma made up ﹤0.01% of Concourse Financial Group Securities's portfolio in Q1 2022, its #2395 holding.
  • Concourse Financial Group Securities first reported a position in Redhill Biopharma in Q3 2021 and has held it in 1 quarter since.
  • Concourse Financial Group Securities's Redhill Biopharma position peaked at $17K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.